Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding

Jean-Pierre Gillet1, Thomas Efferth, Daniel Steinbach

  • 1Research Unit of Cellular Biology, University of Namur, Namur, Belgium. jpierre.gillet@fundp.ac.be

Cancer Research
|December 18, 2004
PubMed

Insights

A novel DNA microarray identifies the expression of ATP-binding cassette (ABC) transporters, crucial in tumor drug resistance. This tool can help detect multidrug resistance in patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacogenomics

Background:

  • Drug resistance in tumors is a major cause of treatment failure.
  • ATP-binding cassette (ABC) transporters are key mechanisms contributing to multidrug resistance.
  • Understanding ABC transporter expression is vital for effective cancer therapy.

Purpose of the Study:

  • To develop and validate a DNA microarray for profiling ABC transporter gene expression.
  • To investigate the role of ABC transporters in multidrug resistance.
  • To assess the potential of the microarray as a diagnostic tool for clinical drug resistance detection.

Main Methods:

  • Development of a low-density DNA microarray targeting 38 genes of the ABC transporter family.
  • Validation using three multidrug-resistant cell lines (CEM/ADR5000, HL60/AR, MCF7/CH1000) and their drug-sensitive parental lines.
  • Confirmation of gene expression changes using quantitative real-time reverse transcription-PCR.

Main Results:

  • The microarray successfully detected overexpression of known drug resistance genes (ABCB1, ABCC1, ABCG2) in resistant cell lines.
  • Identification of overexpression in other ABC transporter genes, suggesting broader roles in multidrug resistance.
  • Results were consistent between microarray analysis and quantitative real-time reverse transcription-PCR.

Conclusions:

  • The developed DNA microarray is a reliable tool for assessing ABC transporter expression profiles.
  • The findings highlight the potential of multiple ABC transporters in contributing to tumor drug resistance.
  • The microarray shows promise as a diagnostic tool for predicting and managing drug resistance in clinical settings.

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...